EcoR1 Capital, LLC
- SEC CIK
- 0001587114
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 75
- 較 2022 年第 2 季 −3
- 總值
- $33.8 億
- 較 2022 年第 2 季 +$5.10 億 (+17.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 11,584,280 | $7.02 億 | 20.8% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 5,183,431 | $3.54 億 | 10.5% | 00.0% | 不變 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 2,999,453 | $3.32 億 | 9.8% | +131,308+4.6% | 加碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 7,521,024 | $1.92 億 | 5.7% | 00.0% | 不變 | 歷史 |
| ARVNArvinas, Inc. | COM | 3,123,300 | $1.39 億 | 4.1% | 00.0% | 不變 | 歷史 |
| XNCRXencor Inc | COM | 5,282,516 | $1.37 億 | 4.1% | +1000.0% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 3,197,500 | $1.36 億 | 4.0% | 00.0% | 不變 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 3,951,566 | $1.12 億 | 3.3% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,460,208 | $9,872 萬 | 2.9% | +3,460,208 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 5,991,479 | $9,802 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 4,163,824 | $9,315 萬 | 2.8% | +440,283+11.8% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 6,638,371 | $9,068 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,015,572 | $7,093 萬 | 2.1% | +1,015,572 | 新進 | 歷史 |
| ZLABZai Lab Ltd | ADR | 2,030,252 | $6,944 萬 | 2.1% | −401,633−16.5% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 4,160,887 | $4,985 萬 | 1.5% | +4,160,887 | 新進 | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 4,488,200 | $4,847 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 2,899,285 | $4,735 萬 | 1.4% | +139,780+5.1% | 加碼 | – |
| DSGNDesign Therapeutics, Inc. | COM | 2,519,268 | $4,212 萬 | 1.2% | −114,910−4.4% | 減碼 | 歷史 |
| SGENSeagen Inc. | COM | 285,793 | $3,911 萬 | 1.2% | −722,835−71.7% | 減碼 | 歷史 |
| ALECAlector, Inc. | COM | 4,056,548 | $3,838 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,801,847 | $3,553 萬 | 1.1% | −2,476,222−57.9% | 減碼 | 歷史 |
| AVIRAtea Pharmaceuticals, Inc. | COM | 6,184,861 | $3,519 萬 | 1.0% | −155,778−2.5% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 3,493,194 | $3,437 萬 | 1.0% | +1,133,386+48.0% | 加碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 2,341,313 | $3,407 萬 | 1.0% | −1,154,630−33.0% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 13,896,543 | $3,113 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 4,753,907 | $2,814 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,330,263 | $2,613 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,421,319 | $1,925 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 796,093 | $1,733 萬 | 0.5% | +796,093 | 新進 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 4,201,414 | $1,521 萬 | 0.4% | +1,899,349+82.5% | 加碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,143,218 | $1,466 萬 | 0.4% | −26,671−2.3% | 減碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 400,000 | $1,396 萬 | 0.4% | −900,000−69.2% | 減碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 690,000 | $1,357 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AKUSAkouos, Inc. | COM | 1,975,984 | $1,336 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,236,352 | $1,301 萬 | 0.4% | +2,944,032+1,007.1% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,117,400 | $1,126 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 3,418,068 | $1,094 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| PSTXPoseida Therapeutics, Inc. | COM | 2,650,000 | $935.5 萬 | 0.3% | +2,650,000 | 新進 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 415,322 | $793.7 萬 | 0.2% | −480,181−53.6% | 減碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 541,108 | $707.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 5,000,000 | $670.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DTILPrecision Biosciences Inc | COM | 5,035,971 | $654.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 17,527 | $618.8 萬 | 0.2% | −107,473−86.0% | 減碼 | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 1,921,310 | $618.7 萬 | 0.2% | 00.0% | 不變 | – |
| RNACCartesian Therapeutics, Inc. | COM | 3,500,000 | $574.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 2,301,980 | $538.7 萬 | 0.2% | −11,867,008−83.8% | 減碼 | 歷史 |
| AVEOAveo Pharmaceuticals, Inc. | COM NEW | 650,489 | $535.4 萬 | 0.2% | +3,000+0.5% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 678,441 | $529.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 1,582,135 | $501.5 萬 | 0.1% | +419,956+36.1% | 加碼 | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $498.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 487,615 | $486.2 萬 | 0.1% | −100,000−17.0% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 3,948,360 | $434.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SURFSurface Oncology, Inc. | COM | 3,924,713 | $408.2 萬 | 0.1% | −728,287−15.7% | 減碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $396.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,496,324 | $339.7 萬 | 0.1% | +1,286,224+612.2% | 加碼 | 歷史 |
| MGNXMacrogenics Inc | COM | 930,955 | $322.1 萬 | 0.1% | +930,955 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 27,208 | $280.9 萬 | 0.1% | +27,208 | 新進 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 175,000 | $209.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 200,000 | $200.4 萬 | 0.1% | 00.0% | 不變 | – |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 200,000 | $200.4 萬 | 0.1% | 00.0% | 不變 | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 200,000 | $200.0 萬 | 0.1% | 00.0% | 不變 | – |
| TPSTTempest Therapeutics, Inc. | COM | 1,031,268 | $179.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 150,000 | $148.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 326,780 | $109.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Turmeric Acquisition CorpG9127T108 | CL A | 100,000 | $100.0 萬 | <0.1% | 00.0% | 不變 | – |
| RETAReata Pharmaceuticals Inc | CL A | 38,467 | $96.7 萬 | <0.1% | −1,937,144−98.1% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 40,970 | $79.6 萬 | <0.1% | +40,970 | 新進 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 40,480 | $77.1 萬 | <0.1% | −239,519−85.5% | 減碼 | 歷史 |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 100,000 | $70.9 萬 | <0.1% | 00.0% | 不變 | – |
| Omega Alpha SpacG6749V107 | CL A | 50,000 | $49.7 萬 | <0.1% | 00.0% | 不變 | – |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 963,333 | – | – | 00.0% | 不變 | – |
| Eucrates Biomedical Acqu CorG3141W122 | *W EXP 10/23/202 | 66,666 | – | – | 00.0% | 不變 | – |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 66,665 | – | – | 00.0% | 不變 | – |
| Turmeric Acquisition CorpG9127T124 | *W EXP 10/08/202 | 33,333 | – | – | 00.0% | 不變 | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,665 | – | – | 00.0% | 不變 | – |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| DSGNDesign Therapeutics, Inc. | COM | – | $106.0 萬 |
2022 年第 2 季之後清倉（11 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,646,260 | $4,353 萬 | 1.5% | 歷史 |
| INCYIncyte Corp | COM | 182,783 | $1,389 萬 | 0.5% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 575,359 | $244.0 萬 | 0.1% | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 98,593 | $150.7 萬 | 0.1% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 215,000 | $147.7 萬 | 0.1% | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 353,701 | $144.0 萬 | 0.1% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 310,960 | $143.7 萬 | 0.1% | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 1,046,700 | $125.6 萬 | <0.1% | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 200,000 | $61.4 萬 | <0.1% | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 200,417 | $42.3 萬 | <0.1% | 歷史 |
| BOLTBolt Biotherapeutics, Inc. | COM | 150,000 | $30.6 萬 | <0.1% | 歷史 |